Business Wire

Mary Kay Inc. Advocates for Advancing Women’s Economic Empowerment and Gender Equality Through Series of Milestone Commitments & Partnerships Around the World

20.7.2021 16:03:00 EEST | Business Wire | Press release

Share

Mary Kay Inc., a global advocate for women’s empowerment and entrepreneurship, has furthered its commitment to advancing gender parity by releasing a position paper welcoming the European Commission’s Gender Equality Strategy for 2020 – 2025 and by joining the Generation Equality Forum Global Action Coalitions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210720005347/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

This month, Mary Kay also joined the “Drivers of change” Program at the Generation Equality Forum in Paris, France (June 30 - July 2). (Graphic: Mary Kay Inc.)

The position paper, which can be accessed here, echoes the strategy of the European Union on gender equality. According to the European Union: “The Strategy presents policy objectives and actions to make significant progress by 2025 towards a gender-equal Europe. The goal is a Union where women and men, girls and boys, in all their diversity, are free to pursue their chosen path in life, have equal opportunities to thrive, and can equally participate in and lead our European society.”

“Discriminatory laws, gender bias and stereotyping, violence against women and girls - these are all global issues and must be tackled in partnership with the public and private sectors and civil society organizations across the world,” said Julia Simon, Chief Legal & Diversity Officer at Mary Kay. “Achieving gender equality is critical to the survival of the planet and the rebuilding of more sustainable and thriving economies and societies.”

This month, Mary Kay also joined the “Drivers of change” Program at the Generation Equality Forum in Paris, France (June 30 - July 2). 26 years after the Beijing Declaration, the Generation Equality Forum, convened by UN Women and co-hosted by the governments of Mexico and France, was the “most critical moment in a generation to invest in gender equality and accelerate momentum for women’s safety, leadership and economic opportunity1.”

Julia Simon participated to a panel titled “Building a Transformative Strategy for Gender-Responsive Procurement,” aiming at creating awareness of the disproportionately complex and interconnected barriers on women’s entrepreneurship and promoting gender-responsive procurement. Globally, 1 in 3 businesses are owned by women2, yet women win only 1% of the procurement spend of governments and large corporations3. Speakers shared insights and concrete advice substantiated by their own journey on how to implement a GRP strategy.

At the Paris Forum, Mary Kay also joined four of the Generation Equality Action Coalitions through policy, programmatic, and advocacy commitments: Economic Justice and Rights; Feminist Action for Climate Justice; Gender-based Violence and Innovation and Technology. 50,000 people virtually engaged in the Forum which gathered 1,000 commitment-makers, recorded $40 billion of investments for gender equality in support of a 5-year plan to act for equal across 6 areas of action.

These engagements are the latest of a series of Mary Kay’s advocacy efforts in support of women’s economic empowerment and gender equality at high level meetings around the world alongside its UN partners and local strategic partners.

  • On March 16, 2021, Deborah Gibbins, Mary Kay’s COO, joined the UN Global Compact Target Gender Equality meeting to discuss how Mary Kay empowers women entrepreneurs in nearly 40 countries. Gibbins highlighted the data freshly released by the World Bank4 revealing that, on average across the world, women have three quarters the legal rights of men. She challenged companies to take a stand against legal discriminations and advocate for reforms to close the gaps so that women can achieve their full potential. The event brought together over 5,000 people from the business sector, the United Nations, member states, and civil society organizations from over 100 countries, with 75% of the participants representing the private sector.
  • On March 24, 2021, on the sidelines of the Commission on the Status of Women (CSW65), Gibbins participated in a panel hosted by the Women’s Empowerment Accelerator (WEA) titled “Women Leading Economic Recovery Through Entrepreneurship” where she highlighted the need for public-private sector partnerships to help shape an enabling ecosystem for women entrepreneurs. Incepted by Mary Kay in collaboration with 5 UN agencies, The Women’s Entrepreneurship Accelerator was featured as an example of the unique impact of multi-partnership to accelerate change.
  • On March 26-April 4, Edita Szabóová, General Manager of Mary Kay Czech Republic and Slovakia, shared remarks at the Equal Pay Day Conference where she stressed the importance of “women supporting women,” and highlighted the work of Mary Kay in nurturing women entrepreneurs through training, leadership, and mentorship. “When women come together, we can achieve extraordinary things for the benefit of women and humanity at large. Because we know that if we lift one, we lift all. At its core, Mary Kay develops and trains entrepreneurs, who, in turn, get to build their own businesses and write their own stories and legacy for their daughters,” said Szabóová.
  • On June 15-16, 2021, at the UN Global Compact Leaders Summit, Gibbins spoke at the “Women In Sustainability: Innovating In A Man’s World” main stage session advocating for women entrepreneurs as the role models needed for the economy and society. She also emphasized the critical mission of the Women’s Entrepreneurship Accelerator incepted by Mary Kay together with 5 UN agency partners: UN Women, the UN Global Compact, International Trade Centre, the International Labour Organization and the UN Development Programme. The Accelerator has committed to educating and empowering 5 million women entrepreneurs over the next 10 years. “Women entrepreneurship will play a key role in the successful pandemic recovery. This is why the mission of the Women’s Entrepreneurship Accelerator is so timely. And, this is why women entrepreneurs need a framework of this magnitude,” said Gibbins. The annual Summit convened virtually more than 25,000 leaders from business, government, the UN, and civil society, to take stock of the state of progress and to drive collective action towards alleviating climate crisis, global pandemic, economic disparities, and social inequalities.
  • On July 6, in Ekaterinburg, Mary Kay joined the International Industrial Trade Fair INNOPROM-2021 the main industrial, trade and export platform in Russia. Guest speaker at a panel hosted by UN Women titled “UN Women Programs for the Promotion and Development of Gender-Based Entrepreneurship,” Mary Kay highlighted the critical importance of gender-responsive procurement strategies and emphasized that the pandemic also brings a unique opportunity to advance action and to support women’s businesses around the world.

About Mary Kay

One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company almost 58 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics, nutritional supplements and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time. Learn more at www.marykay.com

1 https://forum.generationequality.org/home
2 World Bank (2020). Enterprise Surveys, World Bank Gender Data Portal cited by World Bank Blogs (2020) Women entrepreneurs needed – stat!
3 Vazquez and Sherman (2014). Cited by UN Women (2017) The Power of Procurement: How to source from women-owned businesses.
4 Women, Business and the Law, 2021. A report conducted in 190 countries.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Mary Kay Inc. Corporate Communications
Marykay.com/newsroom
(+1) 972.687.5332 or media@mkcorp.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye